5th Stanford Drug Discovery Symposium (SDDS 2021) to be Held Virtually This Year on April 19-20, 2021

Featuring talks from drug discovery leaders, the Stanford Drug Discovery Symposium, April 19-20, 2021, is a free, virtual symposium hosted by Stanford University.
This event offers an exciting opportunity for the public to hear about how drug research and development is done in the U.S. and globally. Esteemed guests are from major pharmaceutical companies, federal policymakers, venture capitalists, start-up companies, and scientists making groundbreaking advances. This year also offers a look into how COVID-19 has led to change in these spaces. Register for free at http://tinyurl.com/SDDS2021.
This year’s SDDS “Lifetime Achievement Award” will be awarded to Doug Lowy, MD, Principal Deputy Director, National Cancer Institute, and John Schiller, Ph.D., Deputy Chief, Laboratory of Cellular Oncology, for their work on the HPV vaccine.
A selection of guest speakers and participants include:
A complete list of speakers and registration information can be found at http://tinyurl.com/SDDS2021.
SDDS 2021 is sponsored in part by Alexandria Ventures, Cytokinetics, Khloris Biosciences, Merck, OptinaDX, REGENXBIO Inc., Stanford Cancer Institute, Stanford Cardiovascular Institute, Santen, Novo Nordisk, Stanford Cardiovascular Health, Vala Sciences, Codex DNA, Servier BioInnovation, and 10X Genomics.
Media Sponsors include Biocom California, Keystone Symposia, and California Life Sciences.
To sponsor, or for other information, press contact: preston@stanford.edu.
Source: Stanford Cardiovascular Institute